So, this drug called Osimertinib inhibits something called T790M mutation in something named EGFR. It’s given for a type of cancer called Non-Small Cell Lung Cancer or NSCLC, for short. You get this drug in two potencies, the 40 mg one, and the beefier 80 mg version, both are film-coated tabs.
The usual scoop is 80 mg, taken every single day, regardless of whether you’ve dined or not. The bottles hold 30 pills each, good for a month’s worth of the stuff at the suggested take. So, Osimertinib is on the hunt for certain EGFR mutations and is used specifically when you have the T790M one.
It’s a bit of a tough nut to crack since it’s more stubborn than other inhibitors. And since it’s super specific, Osimertinib is more like a tailor-made approach for NSCLC patients who have those mutations.
